title: Cutaneous recall phenomenon with vinorelbine.
authors.forename: David
authors.initials: D
authors.lastname: Gómez-Ulloa
authors.forename: Anna Vila
authors.initials: AV
authors.lastname: Bundó
authors.forename: Javier Mateu-de
authors.initials: JM
authors.lastname: Antonio
authors.forename: Edurne
authors.initials: E
authors.lastname: Arriola
authors.forename: David
authors.initials: D
authors.lastname: Conde-Estévez
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000532:radiotherapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D008297:Male; D011855:Radiodermatitis / Q000209:etiology* / Q000473:pathology; D014747:Vinblastine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D000077235:Vinorelbine
chemical_list: D014747:Vinblastine; D000077235:Vinorelbine